# Tririver Capital

Tririver Capital is a Private Equity based in Shanghai, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Founded:** 2008
- **Assets under management:** Undisclosed
- **Website:** www.tririvercapital.com
- **LinkedIn:** https://linkedin.com/company/梧桐三江（上海）创业投资管理中心（有限合伙）

## Regulatory record

- **Reports private funds:** No

## About

Tririver Capital is a China-based investment banking firm focused on the bio and healthcare sector. The firm has made seven investments, including a Seed-II investment in Anticancer Bioscience on October 14, 2021. Tririver Capital has one portfolio exit, BrightGene Bio-Medical Technology, which occurred on November 08, 2019.

## Questions

### What is Tririver Capital's investment focus?

Tririver Capital invests in early-stage Chinese companies, concentrating on seed and start-up rounds. The firm operates as a generalist venture investor based on available records. No specific sector concentrations or thesis statements have been disclosed publicly, making the focus broad by default until confirmed through direct engagement with the firm.

### Who runs investment decisions at Tririver Capital?

Tririver Capital has not disclosed its leadership team, investment committee members, or any named managing partners through public records. The identities of the decision-makers behind the firm's venture investments are not available from open sources as of mid-2026. Allocators must obtain this information directly from the firm.

### How large is Tririver Capital in terms of assets under management?

Tririver Capital does not publicly report assets under management, fund sizes, or total capital deployed. The scale of the firm remains undisclosed across all major databases and public filings. No third-party estimates have been published by any financial news outlet.

### Does Tririver Capital participate in fund commitments or only direct deals?

The available public record only confirms direct early-stage equity investments at the seed and start-up level. Whether Tririver also participates as a limited partner in other venture funds or engages in fund-of-funds activity is not documented in any disclosed materials.

## Related profiles

- [Trip Ventures](https://altss.com/profile/trip-ventures)
- [TriSpan](https://altss.com/profile/trispan)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/tririver-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology